{"DataElement":{"publicId":"4743611","version":"1","preferredName":"Combination Chemotherapy Most Recent Carboplatin WEE1 Inhibitor MK-1775 Administered Time Duration Unit of Measure Code","preferredDefinition":"The response indicating the units of measure used when administering combination chemotherapy using carboplatin and MK-1775.","longName":"MR_CAR_MK1775_UOM_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"4722933","version":"1","preferredName":"Combination Chemotherapy Most Recent Carboplatin WEE1 Inhibitor MK-1775 Administered","preferredDefinition":"Treatment using more than one anticancer drug._Nearest to the present._A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)_A small molecule inhibitor of the tyrosine kinase WEE1 with potential antineoplastic sensitizing activity. MK-1775 selectively targets and inhibits WEE1, a tyrosine kinase that phosphorylates cyclin-dependent kinase 1 (CDC2) to inactivate the CDC2/cyclin B complex. Inhibition of WEE1 activity prevents the phosphorylation of CDC2 and impairs the G2 DNA damage checkpoint. This may lead to apoptosis upon treatment with DNA damaging chemotherapeutic agents. Unlike normal cells, most p53 deficient or mutated human cancers lack the G1 checkpoint as p53 is the key regulator of the G1 checkpoint and these cells rely on the G2 checkpoint for DNA repair to damaged cells. Annulment of the G2 checkpoint may therefore make p53 deficient tumor cells more vulnerable to antineoplastic agents and enhance their cytotoxic effect._The act of having given something (e.g., a medication or test).","longName":"3186477v1.0:4722931v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"3186477","version":"1","preferredName":"Combination Chemotherapy","preferredDefinition":"Treatment using more than one anticancer drug.","longName":"C191","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Combination Chemotherapy","conceptCode":"C191","definition":"Treatment using more than one anticancer drug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AA6C034-CC59-60E3-E040-BB89AD430DF2","latestVersionIndicator":"Yes","beginDate":"2011-01-25","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-01-25","modifiedBy":"ONEDATA","dateModified":"2011-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4722931","version":"1","preferredName":"Most Recent Carboplatin WEE1 Inhibitor MK-1775 Administered","preferredDefinition":"Nearest to the present.:A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04):A small molecule inhibitor of the tyrosine kinase WEE1 with potential antineoplastic sensitizing activity. MK-1775 selectively targets and inhibits WEE1, a tyrosine kinase that phosphorylates cyclin-dependent kinase 1 (CDC2) to inactivate the CDC2/cyclin B complex. Inhibition of WEE1 activity prevents the phosphorylation of CDC2 and impairs the G2 DNA damage checkpoint. This may lead to apoptosis upon treatment with DNA damaging chemotherapeutic agents. Unlike normal cells, most p53 deficient or mutated human cancers lack the G1 checkpoint as p53 is the key regulator of the G1 checkpoint and these cells rely on the G2 checkpoint for DNA repair to damaged cells. Annulment of the G2 checkpoint may therefore make p53 deficient tumor cells more vulnerable to antineoplastic agents and enhance their cytotoxic effect.:The act of having given something (e.g., a medication or test).","longName":"C25577:C1282:C91725:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Most Recent","conceptCode":"C25577","definition":"Nearest to the present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Carboplatin","conceptCode":"C1282","definition":"A second-generation platinum compound with a broad spectrum of antineoplastic properties.  Carboplatin contains a platinum atom complexed with two ammonia groups and a cyclobutane-dicarboxyl residue.  This agent is activated intracellularly to form reactive platinum complexes that bind to nucleophilic groups such as GC-rich sites in DNA, thereby inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links.  These carboplatin-induced DNA and protein effects result in apoptosis and cell growth inhibition.  This agent possesses tumoricidal activity similar to that of its parent compound, cisplatin, but is more stable and less toxic. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adavosertib","conceptCode":"C91725","definition":"A small molecule inhibitor of the tyrosine kinase WEE1 with potential antineoplastic sensitizing activity. Adavosertib selectively targets and inhibits WEE1, a tyrosine kinase that phosphorylates cyclin-dependent kinase 1 (CDK1, CDC2) to inactivate the CDC2/cyclin B complex. Inhibition of WEE1 activity prevents the phosphorylation of CDC2 and impairs the G2 DNA damage checkpoint. This may lead to apoptosis upon treatment with DNA damaging chemotherapeutic agents. Unlike normal cells, most p53 deficient or mutated human cancers lack the G1 checkpoint as p53 is the key regulator of the G1 checkpoint and these cells rely on the G2 checkpoint for DNA repair to damaged cells. Annulment of the G2 checkpoint may therefore make p53 deficient tumor cells more vulnerable to antineoplastic agents and enhance their cytotoxic effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8FFE3B-3600-E261-E050-BB89AD430EB0","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-02-20","modifiedBy":"ONEDATA","dateModified":"2015-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8FFE3B-3611-E261-E050-BB89AD430EB0","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"9149_Theradex_02.20.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2017056","version":"5","preferredName":"Time Duration Unit of Measure Code","preferredDefinition":"Unit of Measure 2-letter code to represent the length of time for an event._The continuum of experience in which events pass from the future through the present to the past._The period of time during which something continues._A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.","longName":"DUR_UOM_CD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"MN","valueDescription":"Minutes","ValueMeaning":{"publicId":"2562322","version":"1","preferredName":"Minutes","longName":"2562322","preferredDefinition":"A unit measure of time equal to 60 seconds.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minute","conceptCode":"C48154","definition":"A unit measure of time equal to 60 seconds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C07F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"REEVESD","dateModified":"2013-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF52-09E3-E040-BB89AD4363D5","beginDate":"2002-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"HR","valueDescription":"Hours","ValueMeaning":{"publicId":"2562324","version":"1","preferredName":"Hours","longName":"2562324","preferredDefinition":"In modern usage, an hour is defined as a unit of time 60 minutes, or 3600 seconds in length. It is approximately 1/24 of a median day.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hour","conceptCode":"C25529","definition":"A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C081-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"REEVESD","dateModified":"2013-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF5C-09E3-E040-BB89AD4363D5","beginDate":"2002-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"DY","valueDescription":"Days","ValueMeaning":{"publicId":"2562325","version":"1","preferredName":"Days","longName":"2562325","preferredDefinition":"The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.       ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Day","conceptCode":"C25301","definition":"The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours, equal to 86 400 seconds. This also refers to a specific day.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C082-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"REEVESD","dateModified":"2013-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF66-09E3-E040-BB89AD4363D5","beginDate":"2002-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"WK","valueDescription":"Weeks","ValueMeaning":{"publicId":"2562323","version":"1","preferredName":"Weeks","longName":"2562323","preferredDefinition":"Any period of seven consecutive days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Week","conceptCode":"C29844","definition":"Any period of seven consecutive days.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C080-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-08-09","endDate":null,"createdBy":"JASUR","dateCreated":"2002-08-09","modifiedBy":"REEVESD","dateModified":"2013-11-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF70-09E3-E040-BB89AD4363D5","beginDate":"2002-08-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"CO","valueDescription":"Course","ValueMeaning":{"publicId":"2569377","version":"1","preferredName":"Course","longName":"2569377","preferredDefinition":"A period of protocol-prescribed activity or intervention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Course","conceptCode":"C25379","definition":"Passage through time; duration; a systematic or/and orderly succession; a sequence, e.g. course of treatment; a mode of action or behavior; natural development, typical manner of proceeding.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC0E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-04-23","modifiedBy":"COOPERM","dateModified":"2008-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF7A-09E3-E040-BB89AD4363D5","beginDate":"2004-04-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"MO","valueDescription":"Month","ValueMeaning":{"publicId":"2569689","version":"1","preferredName":"Month","longName":"2569689","preferredDefinition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Month","conceptCode":"C29846","definition":"One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DD46-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"BMCCURRY","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BF84-09E3-E040-BB89AD4363D5","beginDate":"2004-08-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"SC","valueDescription":"Second","ValueMeaning":{"publicId":"2577221","version":"1","preferredName":"Second","longName":"2577221","preferredDefinition":"The second is the unit of time, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the ground state of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour. Abbreviation Sec. is acceptable in non-scientific usage only.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C42535","definition":"A unit of time, one of the seven base units of the International System of Units (Systeme International d'Unites, SI). The second is the duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the caesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FAB2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EB9B5BC2-BFC0-09E3-E040-BB89AD4363D5","beginDate":"2009-04-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"ONEDATA","dateModified":"2013-11-20","deletedIndicator":"No"},{"value":"YR","valueDescription":"Year","ValueMeaning":{"publicId":"2670939","version":"1","preferredName":"Year","longName":"2670939","preferredDefinition":"The period of time that it takes for Earth to make a complete revolution around the sun; a period of time containing 365 days.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Year","conceptCode":"C29848","definition":"A period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"36BD5C9D-C863-5705-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2007-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB9B4554-3069-0765-E053-4EBD850ADFC5","beginDate":"2022-04-01","endDate":null,"createdBy":"LISU","dateCreated":"2022-04-01","modifiedBy":"ONEDATA","dateModified":"2022-04-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008558","version":"1","preferredName":"Units of Measure","preferredDefinition":"the units of measure for assessment results and dosing.","longName":"UOM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2DECB93-42CA-248A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-28","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2860382","version":"1","preferredName":"Time Duration Unit of Measure Code","preferredDefinition":"the continuum of experience in which events pass from the future through the present to the past.:The period of time during which something continues.:A named quantity in terms of which other quantities are measured or specified used as a standard measurement of same kinds, such as pound or kilogram in measuring weight. (NCI):A system of numbered categories for representation of data.","longName":"C25207:C25330:C25709:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Time","conceptCode":"C25207","definition":"The continuum of experience in which events pass from the future through the present to the past.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Duration","conceptCode":"C25330","definition":"The period of time during which something continues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unit of Measure","conceptCode":"C25709","definition":"A named quantity in terms of which other quantities are measured or specified, used as a standard measurement of like kinds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6735C50D-B59F-1A32-E040-BB89AD434C1D","latestVersionIndicator":"Yes","beginDate":"2009-04-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-04-10","modifiedBy":"ONEDATA","dateModified":"2009-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"EB9B5BC2-BF3C-09E3-E040-BB89AD4363D5","latestVersionIndicator":"Yes","beginDate":"2013-11-20","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-20","modifiedBy":"LISU","dateModified":"2022-04-01","changeDescription":"Replaces v4.0 of this VD in order to edit the PV SC (v4.0 used SEC, corrected PV is SC in this version 5.0)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Units","type":"Preferred Question Text","description":"Units","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1105A90E-7175-ED37-E050-BB89AD43028A","latestVersionIndicator":"Yes","beginDate":"2015-03-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-03-11","modifiedBy":"HARTLEYG","dateModified":"2015-03-11","changeDescription":"9149_Theradex_03.11.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}